NSIM
GMAB icon

North Star Investment Management’s Genmab GMAB Stock Holding History

North Star Investment Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Sell
538
-5
-0.9% -$133 ﹤0.01% 989
2026
Q1 		$14.6K Buy
543
+283
+109% +$8.48K ﹤0.01% 956
2025
Q4 		$8.01K Buy
260
+217
+505% +$6.76K ﹤0.01% 1001
2025
Q3 		$1.32K Buy
+43
New +$1.05K ﹤0.01% 1150

Other funds holding GMAB

Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Orbis Allan Gray
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

North Star Investment Management's GMAB Position: Q2 2026 in Review

North Star Investment Management reduced its Genmab (GMAB) stake by 0.92% in Q2 2026, selling an estimated $133 and leaving 538 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #989.

North Star Investment Management first reported a position in GMAB in Q3 2025 and has held it in 4 quarters since. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • North Star Investment Management held 538 shares of Genmab worth $14.8K as of Q2 2026.
  • North Star Investment Management sold 5 Genmab shares in Q2 2026, an estimated $133.
  • Genmab made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #989 holding.
  • North Star Investment Management first reported a position in Genmab in Q3 2025 and has held it in 4 quarters since.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.